Pneumocystis Jirovecii Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumocystis Jirovecii Pneumonia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-02-16FDA Approved: NEBUPENT — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for NebuPent (pentamidine isethionate) by Fresenius Kabi USA, LLC, to modify the existing approv…
-
CLINICAL_TRIALS trial_result · 2012-12-19Clinical Trial Update: A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia [Phase 3]
Phase 3 trial of trimetrexate with leucovorin rescue for AIDS patients with Pneumocystis jirovecii pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS [NA]
This trial evaluated the safety and efficacy of combining clindamycin with primaquine for treating mild-to-moderate Pneumocystis jirovecii p…
-
FDA approval · 2011-02-08FDA Approved: NEBUPENT — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for NEBUPENT (pentamidine isethionate) submitted by Fresenius Kabi USA, LLC. Nebupent is used to…
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating daily isoniazid to prevent tuberculosis in infants born to HIV-infected mothers was terminated with resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-02-16FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s generic product Sulfamethoxazole and Trimethoprim as an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP) [NA]
A completed clinical trial comparing two injected nutritional supplements in patients with AIDS and Pneumocystis jirovecii pneumonia.
-
CLINICAL_TRIALS trial_result · 2008-09-05Clinical Trial Update: Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART
This clinical trial update reports on the occurrence of Pneumocystis jirovecii pneumonia in HIV-infected patients and how HAART may influenc…
-
FDA label_change · 2007-06-05FDA Approved: BACTRIM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for BACTRIM (sulfamethoxazole and trimethoprim) to modify the labeling.